The experimental drug IC7Fc reduces artery-clogging fats and inflammation in mice, pointing to a potential new strategy for preventing heart disease. Earlier work linked the experimental drug ‘IC7Fc’ to improvements in type 2 diabetes, and new research now points to…
Continue reading with a subscription
This article is available to subscribers. Subscribe to read it in full, or sign in if you already have an account.